{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["AKT", "AKT inhibitor", "signal transduction", "skin cancer"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32962182", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "15"}, "DateRevised": {"Year": "2021", "Month": "03", "Day": "15"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "09", "Day": "18"}], "ELocationID": ["6869", "10.3390/ijms21186869"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "21", "Issue": "18", "PubDate": {"Year": "2020", "Month": "Sep", "Day": "18"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Alternative Options for Skin Cancer Therapy via Regulation of AKT and Related Signaling Pathways.", "Abstract": {"AbstractText": ["Global environmental pollution has led to human exposure to ultraviolet (UV) radiation due to the damaged ozone layer, thereby increasing the incidence and death rate of skin cancer including both melanoma and non-melanoma. Overexpression and activation of V-akt murine thymoma viral oncogene homolog (AKT, also known as protein kinase B) and related signaling pathways are major factors contributing to many cancers including lung cancer, esophageal squamous cell carcinoma and skin cancer. Although BRAF inhibitors are used to treat melanoma, further options are needed due to treatment resistance and poor efficacy. Depletion of AKT expression and activation, and related signaling cascades by its inhibitors, decreases the growth of skin cancer and metastasis. Here we have focused the effects of AKT and related signaling (PI3K/AKT/mTOR) pathways by regulators derived from plants and suggest the need for efficient treatment in skin cancer therapy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Korean Medicine, Dongshin University, Naju, Jeonnam 58245, Korea."}], "LastName": "Hwang", "ForeName": "Sun-Young", "Initials": "SY"}, {"Identifier": ["0000-0002-2751-8577"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dental Pharmacology, School of Dentistry and Institute of Oral Bioscience, Jeonbuk National University, Jeonju 54896, Korea."}], "LastName": "Chae", "ForeName": "Jung-Il", "Initials": "JI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, College of Pharmacy, Mokpo National University, Jeonnam 58554, Korea."}], "LastName": "Kwak", "ForeName": "Ah-Won", "Initials": "AW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Korean Medicine, Dongshin University, Naju, Jeonnam 58245, Korea."}], "LastName": "Lee", "ForeName": "Mee-Hyun", "Initials": "MH"}, {"Identifier": ["0000-0002-4062-4016"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, College of Pharmacy, Mokpo National University, Jeonnam 58554, Korea."}, {"Identifier": [], "Affiliation": "Department of Biomedicine, Health & Life Convergence Sciences, BK21 FOUR, Mokpo National University, Jeonnam 58554, Korea."}], "LastName": "Shim", "ForeName": "Jung-Hyun", "Initials": "JH"}], "GrantList": [{"GrantID": "2019R1A2C1005899", "Agency": "National Research Foundation of Korea", "Country": ""}, {"GrantID": "2020R1I1A3070556", "Agency": "National Research Foundation of Korea", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Kinase Inhibitors"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Melanoma"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Protein Kinase Inhibitors"}, {"QualifierName": ["antagonists & inhibitors", "chemistry", "genetics", "metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Skin Neoplasms"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J. Clin. 2020;70:7\u201330. doi: 10.3322/caac.21590.", "ArticleIdList": ["10.3322/caac.21590", "31912902"]}, {"Citation": "Global Burden of Disease Cancer Collaboration. Fitzmaurice C., Abate D., Abbasi N., Abbastabar H., Abd-Allah F., Abdel-Rahman O., Abdelalim A., Abdoli A., Abdollahpour I., et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019 doi: 10.1001/jamaoncol.2019.2996.", "ArticleIdList": ["10.1001/jamaoncol.2019.2996", "PMC6777271", "31560378"]}, {"Citation": "Tran D.A., Coronado A.C., Sarker S., Alvi R. Estimating the health care costs of non-melanoma skin cancer in Saskatchewan using physician billing data. Curr. Oncol. 2019;26:114\u2013118. doi: 10.3747/co.26.4557.", "ArticleIdList": ["10.3747/co.26.4557", "PMC6476453", "31043813"]}, {"Citation": "Guy G.P., Jr., Machlin S.R., Ekwueme D.U., Yabroff K.R. Prevalence and costs of skin cancer treatment in the U.S., 2002\u20132006 and 2007\u20132011. Am. J. Prev. Med. 2015;48:183\u2013187. doi: 10.1016/j.amepre.2014.08.036.", "ArticleIdList": ["10.1016/j.amepre.2014.08.036", "PMC4603424", "25442229"]}, {"Citation": "Apalla Z., Nashan D., Weller R.B., Castellsague X. Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches. Dermatol. Ther. 2017;7:5\u201319. doi: 10.1007/s13555-016-0165-y.", "ArticleIdList": ["10.1007/s13555-016-0165-y", "PMC5289116", "28150105"]}, {"Citation": "Wrobel S., Przybylo M., Stepien E. The Clinical Trial Landscape for Melanoma Therapies. J. Clin. Med. 2019;8:368. doi: 10.3390/jcm8030368.", "ArticleIdList": ["10.3390/jcm8030368", "PMC6463026", "30884760"]}, {"Citation": "Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394\u2013424. doi: 10.3322/caac.21492.", "ArticleIdList": ["10.3322/caac.21492", "30207593"]}, {"Citation": "Khavari P.A. Modelling cancer in human skin tissue. Nat. Rev. Cancer. 2006;6:270\u2013280. doi: 10.1038/nrc1838.", "ArticleIdList": ["10.1038/nrc1838", "16541145"]}, {"Citation": "Roh E., Lee M.H., Zykova T.A., Zhu F., Nadas J., Kim H.G., Bae K.B., Li Y., Cho Y.Y., Curiel-Lewandrowski C., et al. Targeting PRPK and TOPK for skin cancer prevention and therapy. Oncogene. 2018;37:5633\u20135647. doi: 10.1038/s41388-018-0350-9.", "ArticleIdList": ["10.1038/s41388-018-0350-9", "PMC6195829", "29904102"]}, {"Citation": "Lee M.H., Lim D.Y., Kim M.O., Lee S.Y., Shin S.H., Kim J.Y., Kim S.H., Kim D.J., Jung S.K., Yao K., et al. Genetic ablation of caspase-7 promotes solar-simulated light-induced mouse skin carcinogenesis: The involvement of keratin-17. Carcinogenesis. 2015;36:1372\u20131380. doi: 10.1093/carcin/bgv110.", "ArticleIdList": ["10.1093/carcin/bgv110", "PMC4635665", "26271098"]}, {"Citation": "Kim J.E., Lee K.W. Molecular Targets of Phytochemicals for Skin Inflammation. Curr. Pharm. Des. 2018;24:1533\u20131550. doi: 10.2174/1381612824666180426113247.", "ArticleIdList": ["10.2174/1381612824666180426113247", "29701147"]}, {"Citation": "Zhao R., Choi B.Y., Lee M.H., Bode A.M., Dong Z. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer. EBioMedicine. 2016;8:30\u201339. doi: 10.1016/j.ebiom.2016.04.017.", "ArticleIdList": ["10.1016/j.ebiom.2016.04.017", "PMC4919535", "27428416"]}, {"Citation": "Pal H.C., Hunt K.M., Diamond A., Elmets C.A., Afaq F. Phytochemicals for the Management of Melanoma. Mini Rev. Med. Chem. 2016;16:953\u2013979.", "ArticleIdList": ["PMC4980238", "26864554"]}, {"Citation": "Lee M.H., Huang Z., Kim D.J., Kim S.H., Kim M.O., Lee S.Y., Xie H., Park S.J., Kim J.Y., Kundu J.K., et al. Direct targeting of MEK1/2 and RSK2 by silybin induces cell-cycle arrest and inhibits melanoma cell growth. Cancer Prev. Res. 2013;6:455\u2013465. doi: 10.1158/1940-6207.CAPR-12-0425.", "ArticleIdList": ["10.1158/1940-6207.CAPR-12-0425", "PMC3644346", "23447564"]}, {"Citation": "Nikas I.P., Paschou S.A., Ryu H.S. The Role of Nicotinamide in Cancer Chemoprevention and Therapy. Biomolecules. 2020;10:477. doi: 10.3390/biom10030477.", "ArticleIdList": ["10.3390/biom10030477", "PMC7175378", "32245130"]}, {"Citation": "Song M., Bode A.M., Dong Z., Lee M.H. AKT as a Therapeutic Target for Cancer. Cancer Res. 2019;79:1019\u20131031. doi: 10.1158/0008-5472.CAN-18-2738.", "ArticleIdList": ["10.1158/0008-5472.CAN-18-2738", "30808672"]}, {"Citation": "Shariati M., Meric-Bernstam F. Targeting AKT for cancer therapy. Expert Opin. Investig. Drugs. 2019;28:977\u2013988. doi: 10.1080/13543784.2019.1676726.", "ArticleIdList": ["10.1080/13543784.2019.1676726", "PMC6901085", "31594388"]}, {"Citation": "Kumar C.C., Madison V. AKT crystal structure and AKT-specific inhibitors. Oncogene. 2005;24:7493\u20137501. doi: 10.1038/sj.onc.1209087.", "ArticleIdList": ["10.1038/sj.onc.1209087", "16288296"]}, {"Citation": "Fayard E., Tintignac L.A., Baudry A., Hemmings B.A. Protein kinase B/Akt at a glance. J. Cell Sci. 2005;118:5675\u20135678. doi: 10.1242/jcs.02724.", "ArticleIdList": ["10.1242/jcs.02724", "16339964"]}, {"Citation": "Song M., Liu X., Liu K., Zhao R., Huang H., Shi Y., Zhang M., Zhou S., Xie H., Chen H., et al. Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo. Mol. Cancer Ther. 2018;17:1540\u20131553. doi: 10.1158/1535-7163.MCT-17-0823.", "ArticleIdList": ["10.1158/1535-7163.MCT-17-0823", "PMC6715294", "29695636"]}, {"Citation": "Soares C.D., Borges C.F., Sena-Filho M., Almeida O.P., Stelini R.F., Cintra M.L., Graner E., Zecchin K.G., Jorge J. Prognostic significance of cyclooxygenase 2 and phosphorylated Akt1 overexpression in primary nonmetastatic and metastatic cutaneous melanomas. Melanoma Res. 2017;27:448\u2013456. doi: 10.1097/CMR.0000000000000368.", "ArticleIdList": ["10.1097/CMR.0000000000000368", "28604419"]}, {"Citation": "Slipicevic A., Holm R., Nguyen M.T., Bohler P.J., Davidson B., Florenes V.A. Expression of activated Akt and PTEN in malignant melanomas: Relationship with clinical outcome. Am. J. Clin. Pathol. 2005;124:528\u2013536. doi: 10.1309/YT58WWMTA6YR1PRV.", "ArticleIdList": ["10.1309/YT58WWMTA6YR1PRV", "16146807"]}, {"Citation": "Cho J.H., Robinson J.P., Arave R.A., Burnett W.J., Kircher D.A., Chen G., Davies M.A., Grossmann A.H., VanBrocklin M.W., McMahon M., et al. AKT1 Activation Promotes Development of Melanoma Metastases. Cell Rep. 2015;13:898\u2013905. doi: 10.1016/j.celrep.2015.09.057.", "ArticleIdList": ["10.1016/j.celrep.2015.09.057", "PMC4646731", "26565903"]}, {"Citation": "Li X., Yang Z., Song W., Zhou L., Li Q., Tao K., Zhou J., Wang X., Zheng Z., You N., et al. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway. Int. J. Oncol. 2013;43:793\u2013802. doi: 10.3892/ijo.2013.1992.", "ArticleIdList": ["10.3892/ijo.2013.1992", "23807724"]}, {"Citation": "Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2002;2:161\u2013174. doi: 10.1038/nrc745.", "ArticleIdList": ["10.1038/nrc745", "11990853"]}, {"Citation": "Song N.R., Lee E., Byun S., Kim J.E., Mottamal M., Park J.H., Lim S.S., Bode A.M., Lee H.J., Lee K.W., et al. Isoangustone A, a novel licorice compound, inhibits cell proliferation by targeting PI3K, MKK4, and MKK7 in human melanoma. Cancer Prev. Res. 2013;6:1293\u20131303. doi: 10.1158/1940-6207.CAPR-13-0134.", "ArticleIdList": ["10.1158/1940-6207.CAPR-13-0134", "PMC3855899", "24104352"]}, {"Citation": "Jung S.K., Kim J.E., Lee S.Y., Lee M.H., Byun S., Kim Y.A., Lim T.G., Reddy K., Huang Z., Bode A.M., et al. The P110 subunit of PI3-K is a therapeutic target of acacetin in skin cancer. Carcinogenesis. 2014;35:123\u2013130. doi: 10.1093/carcin/bgt266.", "ArticleIdList": ["10.1093/carcin/bgt266", "PMC3895936", "23913940"]}, {"Citation": "Antony J., Saikia M., Vinod V., Nath L.R., Katiki M.R., Murty M.S., Paul A., Shabna A., Chandran H., Joseph S.M., et al. DW-F5: A novel formulation against malignant melanoma from Wrightia tinctoria. Sci. Rep. 2015;5:11107. doi: 10.1038/srep11107.", "ArticleIdList": ["10.1038/srep11107", "PMC4650611", "26061820"]}, {"Citation": "Arcidiacono P., Stabile A.M., Ragonese F., Pistilli A., Calvieri S., Bottoni U., Crisanti A., Spaccapelo R., Rende M. Anticarcinogenic activities of sulforaphane are influenced by Nerve Growth Factor in human melanoma A375 cells. Food Chem. Toxicol. 2018;113:154\u2013161. doi: 10.1016/j.fct.2018.01.051.", "ArticleIdList": ["10.1016/j.fct.2018.01.051", "29407470"]}, {"Citation": "Olas B., Skalski B., Ulanowska K. The Anticancer Activity of Sea Buckthorn [Elaeagnus rhamnoides (L.) A. Nelson] Front. Pharmacol. 2018;9:232. doi: 10.3389/fphar.2018.00232.", "ArticleIdList": ["10.3389/fphar.2018.00232", "PMC5861756", "29593547"]}, {"Citation": "Duan R., Liang X., Chai B., Zhou Y., Du H., Suo Y., Chen Z., Li Q., Huang X. Isorhamnetin Induces Melanoma Cell Apoptosis via the PI3K/Akt and NF-kappaB Pathways. Biomed. Res. Int. 2020;2020:1057943. doi: 10.1155/2020/1057943.", "ArticleIdList": ["10.1155/2020/1057943", "PMC7225865", "32461960"]}, {"Citation": "Guo P., Wang Y.W., Weng B.X., Li X.K., Yang S.L., Ye F.Q. Synthesis, anti-tumor activity, and structure-activity relationships of curcumol derivatives. J. Asian Nat. Prod. Res. 2014;16:53\u201358. doi: 10.1080/10286020.2013.857660.", "ArticleIdList": ["10.1080/10286020.2013.857660", "24266515"]}, {"Citation": "Ning N., Liu S., Liu X., Tian Z., Jiang Y., Yu N., Tan B., Feng H., Feng X., Zou L. Curcumol inhibits the proliferation and metastasis of melanoma via the miR-152-3p/PI3K/AKT and ERK/NF-kappaB signaling pathways. J. Cancer. 2020;11:1679\u20131692. doi: 10.7150/jca.38624.", "ArticleIdList": ["10.7150/jca.38624", "PMC7052881", "32194780"]}, {"Citation": "Dong R., Guo J., Zhang Z., Zhou Y., Hua Y. Polyphyllin I inhibits gastric cancer cell proliferation by downregulating the expression of fibroblast activation protein alpha (FAP) and hepatocyte growth factor (HGF) in cancer-associated fibroblasts. Biochem. Biophys. Res. Commun. 2018;497:1129\u20131134. doi: 10.1016/j.bbrc.2018.02.193.", "ArticleIdList": ["10.1016/j.bbrc.2018.02.193", "29499193"]}, {"Citation": "Chang J., Li Y., Wang X., Hu S., Wang H., Shi Q., Wang Y., Yang Y. Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/beta-catenin pathway in vitro and in vivo. Sci. Rep. 2017;7:7605. doi: 10.1038/s41598-017-07194-9.", "ArticleIdList": ["10.1038/s41598-017-07194-9", "PMC5548759", "28790389"]}, {"Citation": "Long J., Pi X. Polyphyllin I Promoted Melanoma Cells Autophagy and Apoptosis via PI3K/Akt/mTOR Signaling Pathway. Biomed. Res. Int. 2020;2020:5149417. doi: 10.1155/2020/5149417.", "ArticleIdList": ["10.1155/2020/5149417", "PMC7383336", "32733943"]}, {"Citation": "Kim D.J., Roh E., Lee M.H., Oi N., Lim D.Y., Kim M.O., Cho Y.Y., Pugliese A., Shim J.H., Chen H., et al. Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity. Cancer Res. 2016;76:1146\u20131157. doi: 10.1158/0008-5472.CAN-15-0442.", "ArticleIdList": ["10.1158/0008-5472.CAN-15-0442", "PMC4775427", "26676750"]}, {"Citation": "Kim D.J., Lee M.H., Liu K., Lim D.Y., Roh E., Chen H., Kim S.H., Shim J.H., Kim M.O., Li W., et al. Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODC. Carcinogenesis. 2017;38:1136\u20131146. doi: 10.1093/carcin/bgx082.", "ArticleIdList": ["10.1093/carcin/bgx082", "PMC5862242", "29029040"]}, {"Citation": "Potocnjak I., Simic L., Gobin I., Vukelic I., Domitrovic R. Antitumor activity of luteolin in human colon cancer SW620 cells is mediated by the ERK/FOXO3a signaling pathway. Toxicol. In Vitro. 2020;66:104852. doi: 10.1016/j.tiv.2020.104852.", "ArticleIdList": ["10.1016/j.tiv.2020.104852", "32268164"]}, {"Citation": "Masraksa W., Tanasawet S., Hutamekalin P., Wongtawatchai T., Sukketsiri W. Luteolin attenuates migration and invasion of lung cancer cells via suppressing focal adhesion kinase and non-receptor tyrosine kinase signaling pathway. Nutr. Res. Pract. 2020;14:127\u2013133. doi: 10.4162/nrp.2020.14.2.127.", "ArticleIdList": ["10.4162/nrp.2020.14.2.127", "PMC7075744", "32256987"]}, {"Citation": "Byun S., Lee K.W., Jung S.K., Lee E.J., Hwang M.K., Lim S.H., Bode A.M., Lee H.J., Dong Z. Luteolin inhibits protein kinase C(epsilon) and c-Src activities and UVB-induced skin cancer. Cancer Res. 2010;70:2415\u20132423. doi: 10.1158/0008-5472.CAN-09-4093.", "ArticleIdList": ["10.1158/0008-5472.CAN-09-4093", "20215519"]}, {"Citation": "Yao X., Jiang W., Yu D., Yan Z. Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway. Food Funct. 2019;10:703\u2013712. doi: 10.1039/C8FO02013B.", "ArticleIdList": ["10.1039/C8FO02013B", "30663726"]}, {"Citation": "Xia X., May B.H., Zhang A.L., Guo X., Lu C., Xue C.C., Huang Q. Chinese Herbal Medicines for Rheumatoid Arthritis: Text-Mining the Classical Literature for Potentially Effective Natural Products. Evid. Based Complement Alternat Med. 2020;2020:7531967. doi: 10.1155/2020/7531967.", "ArticleIdList": ["10.1155/2020/7531967", "PMC7206865", "32419824"]}, {"Citation": "Liu Y., Liu C., Tan T., Li S., Tang S., Chen X. Sinomenine sensitizes human gastric cancer cells to cisplatin through negative regulation of PI3K/AKT/Wnt signaling pathway. Anticancer Drugs. 2019;30:983\u2013990. doi: 10.1097/CAD.0000000000000834.", "ArticleIdList": ["10.1097/CAD.0000000000000834", "PMC6824511", "31609766"]}, {"Citation": "Sun Z., Zheng L., Liu X., Xing W., Liu X. Sinomenine inhibits the growth of melanoma by enhancement of autophagy via PI3K/AKT/mTOR inhibition. Drug Des. Devel. Ther. 2018;12:2413\u20132421. doi: 10.2147/DDDT.S155798.", "ArticleIdList": ["10.2147/DDDT.S155798", "PMC6084074", "30122899"]}, {"Citation": "Periyannan V., Annamalai V., Veerasamy V. Syringic acid modulates molecular marker-involved cell proliferation, survival, apoptosis, inflammation, and angiogenesis in DMBA-induced oral squamous cell carcinoma in Syrian hamsters. J. Biochem. Mol. Toxicol. 2020:e22574. doi: 10.1002/jbt.22574.", "ArticleIdList": ["10.1002/jbt.22574", "32640096"]}, {"Citation": "Cho H.D., Kim J.H., Won Y.S., Moon K.D., Seo K.I. Inhibitory Effects of Pectinase-Treated Prunus Mume Fruit Concentrate on Colorectal Cancer Proliferation and Angiogenesis of Endothelial Cells. J. Food Sci. 2019;84:3284\u20133295. doi: 10.1111/1750-3841.14824.", "ArticleIdList": ["10.1111/1750-3841.14824", "31618463"]}, {"Citation": "Ha S.J., Lee J., Park J., Kim Y.H., Lee N.H., Kim Y.E., Song K.M., Chang P.S., Jeong C.H., Jung S.K. Syringic acid prevents skin carcinogenesis via regulation of NoX and EGFR signaling. Biochem. Pharmacol. 2018;154:435\u2013445. doi: 10.1016/j.bcp.2018.06.007.", "ArticleIdList": ["10.1016/j.bcp.2018.06.007", "29886055"]}, {"Citation": "Cao C., Han D., Su Y., Ge Y., Chen H., Xu A. Ginkgo biloba exocarp extracts induces autophagy in Lewis lung cancer cells involving AMPK/mTOR/p70S6k signaling pathway. Biomed. Pharmacother. 2017;93:1128\u20131135. doi: 10.1016/j.biopha.2017.07.036.", "ArticleIdList": ["10.1016/j.biopha.2017.07.036", "28738521"]}, {"Citation": "Han D., Cao C., Su Y., Wang J., Sun J., Chen H., Xu A. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/beta-catenin-VEGF signaling pathway in Lewis lung cancer. J. Ethnopharmacol. 2016;192:406\u2013412. doi: 10.1016/j.jep.2016.09.018.", "ArticleIdList": ["10.1016/j.jep.2016.09.018", "27649680"]}, {"Citation": "Cao C., Su Y., Gao Y., Luo C., Yin L., Zhao Y., Chen H., Xu A. Ginkgo biloba Exocarp Extract Inhibits the Metastasis of B16-F10 Melanoma Involving PI3K/Akt/NF-kappaB/MMP-9 Signaling Pathway. Evid. Based Complement Alternat Med. 2018;2018:4969028. doi: 10.1155/2018/4969028.", "ArticleIdList": ["10.1155/2018/4969028", "PMC6036818", "30046339"]}, {"Citation": "Zhang H., Tan Y.P., Zhao L., Wang L., Fu N.J., Zheng S.P., Shen X.F. Anticancer activity of dietary xanthone alpha-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1. Cell Death Dis. 2020;11:63. doi: 10.1038/s41419-020-2227-4.", "ArticleIdList": ["10.1038/s41419-020-2227-4", "PMC6981176", "31980595"]}, {"Citation": "Chien H.J., Ying T.H., Hsieh S.C., Lin C.L., Yu Y.L., Kao S.H., Hsieh Y.H. alpha-Mangostin attenuates stemness and enhances cisplatin-induced cell death in cervical cancer stem-like cells through induction of mitochondrial-mediated apoptosis. J. Cell. Physiol. 2020;235:5590\u20135601. doi: 10.1002/jcp.29489.", "ArticleIdList": ["10.1002/jcp.29489", "31960449"]}, {"Citation": "Wang F., Ma H., Liu Z., Huang W., Xu X., Zhang X. alpha-Mangostin inhibits DMBA/TPA-induced skin cancer through inhibiting inflammation and promoting autophagy and apoptosis by regulating PI3K/Akt/mTOR signaling pathway in mice. Biomed. Pharmacother. 2017;92:672\u2013680. doi: 10.1016/j.biopha.2017.05.129.", "ArticleIdList": ["10.1016/j.biopha.2017.05.129", "28582759"]}, {"Citation": "Sellam L.S., Zappasodi R., Chettibi F., Djennaoui D., Yahi-Ait Mesbah N., Amir-Tidadini Z.C., Touil-Boukoffa C., Ouahioune W., Merghoub T., Bourouba M. Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism. Arch. Biochem. Biophys. 2020;690:108479. doi: 10.1016/j.abb.2020.108479.", "ArticleIdList": ["10.1016/j.abb.2020.108479", "32679194"]}, {"Citation": "Tilley C., Deep G., Agarwal C., Wempe M.F., Biedermann D., Valentova K., Kren V., Agarwal R. Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation. Mol. Carcinog. 2016;55:3\u201314. doi: 10.1002/mc.22253.", "ArticleIdList": ["10.1002/mc.22253", "PMC4461565", "25492239"]}, {"Citation": "Dheeraj A., Rigby C.M., O\u2019Bryant C.L., Agarwal C., Singh R.P., Deep G., Agarwal R. Silibinin Treatment Inhibits the Growth of Hedgehog Inhibitor-Resistant Basal Cell Carcinoma Cells via Targeting EGFR-MAPK-Akt and Hedgehog Signaling. Photochem. Photobiol. 2017;93:999\u20131007. doi: 10.1111/php.12727.", "ArticleIdList": ["10.1111/php.12727", "PMC5500419", "28120452"]}, {"Citation": "Pourhanifeh M.H., Mottaghi R., Razavi Z.S., Shafiee A., Hajighadimi S., Mirzaei H. Therapeutic Applications of Curcumin and its Novel Formulations in the Treatment of Bladder Cancer: A Review of Current Evidence. Anticancer Agents Med. Chem. 2020 doi: 10.2174/1871520620666200807223832.", "ArticleIdList": ["10.2174/1871520620666200807223832", "32767956"]}, {"Citation": "Avila-Galvez M.A., Gimenez-Bastida J.A., Espin J.C., Gonzalez-Sarrias A. Dietary Phenolics against Breast Cancer. A Critical Evidence-Based Review and Future Perspectives. Int. J. Mol. Sci. 2020;21:5718. doi: 10.3390/ijms21165718.", "ArticleIdList": ["10.3390/ijms21165718", "PMC7461055", "32784973"]}, {"Citation": "Zhao G., Han X., Zheng S., Li Z., Sha Y., Ni J., Sun Z., Qiao S., Song Z. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells. Oncol. Rep. 2016;35:1065\u20131074. doi: 10.3892/or.2015.4413.", "ArticleIdList": ["10.3892/or.2015.4413", "26573768"]}, {"Citation": "Yan F., Liao R., Silva M., Li S., Jiang Y., Peng T., Lazarovici P., Zheng W. Pristimerin-induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway. J. Cell. Mol. Med. 2020;24:6208\u20136219. doi: 10.1111/jcmm.15249.", "ArticleIdList": ["10.1111/jcmm.15249", "PMC7294164", "32347651"]}, {"Citation": "Li C.Y., Wang Q., Wang X.M., Li G.X., Shen S., Wei X.L. Gambogic acid exhibits anti-metastatic activity on malignant melanoma mainly through inhibition of PI3K/Akt and ERK signaling pathways. Eur. J. Pharmacol. 2019;864:172719. doi: 10.1016/j.ejphar.2019.172719.", "ArticleIdList": ["10.1016/j.ejphar.2019.172719", "31586634"]}, {"Citation": "Lim H.N., Baek S.B., Jung H.J. Bee Venom and Its Peptide Component Melittin Suppress Growth and Migration of Melanoma Cells via Inhibition of PI3K/AKT/mTOR and MAPK Pathways. Molecules. 2019;24:929. doi: 10.3390/molecules24050929.", "ArticleIdList": ["10.3390/molecules24050929", "PMC6429308", "30866426"]}, {"Citation": "Yang J., Xiao P., Sun J., Guo L. Anticancer effects of kaempferol in A375 human malignant melanoma cells are mediated via induction of apoptosis, cell cycle arrest, inhibition of cell migration and downregulation of m-TOR/PI3K/AKT pathway. J. BUON. 2018;23:218\u2013223.", "ArticleIdList": ["29552787"]}, {"Citation": "Carpi S., Polini B., Poli G., Alcantara Barata G., Fogli S., Romanini A., Tuccinardi T., Guella G., Frontini F.P., Nieri P., et al. Anticancer Activity of Euplotin C, Isolated from the Marine Ciliate Euplotes crassus, Against Human Melanoma Cells. Mar. Drugs. 2018;16:166. doi: 10.3390/md16050166.", "ArticleIdList": ["10.3390/md16050166", "PMC5983297", "29772645"]}, {"Citation": "Jiang Q.Q., Liu W.B. Lycorine inhibits melanoma A375 cell growth and metastasis through the inactivation of the PI3K/AKT signaling pathway. Med. Sci. 2018;34:33\u201338. doi: 10.1051/medsci/201834f106.", "ArticleIdList": ["10.1051/medsci/201834f106", "30403172"]}, {"Citation": "Peng X., Wang Z., Liu Y., Peng X., Liu Y., Zhu S., Zhang Z., Qiu Y., Jin M., Wang R., et al. Oxyfadichalcone C inhibits melanoma A375 cell proliferation and metastasis via suppressing PI3K/Akt and MAPK/ERK pathways. Life Sci. 2018;206:35\u201344. doi: 10.1016/j.lfs.2018.05.032.", "ArticleIdList": ["10.1016/j.lfs.2018.05.032", "29782872"]}, {"Citation": "Chen X.Y., Li D.F., Han J.C., Wang B., Dong Z.P., Yu L.N., Pan Z.H., Qu C.J., Chen Y., Sun S.G., et al. Reprogramming induced by isoliquiritigenin diminishes melanoma cachexia through mTORC2-AKT-GSK3beta signaling. Oncotarget. 2017;8:34565\u201334575. doi: 10.18632/oncotarget.16655.", "ArticleIdList": ["10.18632/oncotarget.16655", "PMC5470991", "28410220"]}, {"Citation": "Zou N., Wei Y., Li F., Yang Y., Cheng X., Wang C. The inhibitory effects of compound Muniziqi granule against B16 cells and harmine induced autophagy and apoptosis by inhibiting Akt/mTOR pathway. BMC Complement Altern Med. 2017;17:517. doi: 10.1186/s12906-017-2017-4.", "ArticleIdList": ["10.1186/s12906-017-2017-4", "PMC5712103", "29197358"]}, {"Citation": "Zhao G., Han X., Cheng W., Ni J., Zhang Y., Lin J., Song Z. Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells. Oncol. Rep. 2017;37:2277\u20132285. doi: 10.3892/or.2017.5450.", "ArticleIdList": ["10.3892/or.2017.5450", "28260058"]}, {"Citation": "Shih Y.L., Chou H.M., Chou H.C., Lu H.F., Chu Y.L., Shang H.S., Chung J.G. Casticin impairs cell migration and invasion of mouse melanoma B16F10 cells via PI3K/AKT and NF-kappaB signaling pathways. Environ. Toxicol. 2017;32:2097\u20132112. doi: 10.1002/tox.22417.", "ArticleIdList": ["10.1002/tox.22417", "28444820"]}, {"Citation": "Chen H.Y., Jiang Y.W., Kuo C.L., Way T.D., Chou Y.C., Chang Y.S., Chung J.G. Chrysin inhibit human melanoma A375.S2 cell migration and invasion via affecting MAPK signaling and NF-kappaB signaling pathway in vitro. Environ. Toxicol. 2019;34:434\u2013442. doi: 10.1002/tox.22697.", "ArticleIdList": ["10.1002/tox.22697", "30578657"]}, {"Citation": "Liu J.F., Lai K.C., Peng S.F., Maraming P., Huang Y.P., Huang A.C., Chueh F.S., Huang W.W., Chung J.G. Berberine Inhibits Human Melanoma A375.S2 Cell Migration and Invasion via Affecting the FAK, uPA, and NF-kappaB Signaling Pathways and Inhibits PLX4032 Resistant A375.S2 Cell Migration In Vitro. Molecules. 2018;23:2019. doi: 10.3390/molecules23082019.", "ArticleIdList": ["10.3390/molecules23082019", "PMC6222729", "30104528"]}, {"Citation": "Zeng N., Hongbo T., Xu Y., Wu M., Wu Y. Anticancer activity of caffeic acid nbutyl ester against A431 skin carcinoma cell line occurs via induction of apoptosis and inhibition of the mTOR/PI3K/AKT signaling pathway. Mol. Med. Rep. 2018;17:5652\u20135657.", "ArticleIdList": ["PMC5866006", "29436638"]}, {"Citation": "Basu A.K. DNA Damage, Mutagenesis and Cancer. Int. J. Mol. Sci. 2018;19:970. doi: 10.3390/ijms19040970.", "ArticleIdList": ["10.3390/ijms19040970", "PMC5979367", "29570697"]}, {"Citation": "Lin H., Lin L., Choi Y., Michniak-Kohn B. Development and in-vitro evaluation of co-loaded berberine chloride and evodiamine ethosomes for treatment of melanoma. Int. J. Pharm. 2020;581:119278. doi: 10.1016/j.ijpharm.2020.119278.", "ArticleIdList": ["10.1016/j.ijpharm.2020.119278", "32229284"]}, {"Citation": "Moolakkadath T., Aqil M., Ahad A., Imam S.S., Praveen A., Sultana Y., Mujeeb M., Iqbal Z. Fisetin loaded binary ethosomes for management of skin cancer by dermal application on UV exposed mice. Int. J. Pharm. 2019;560:78\u201391. doi: 10.1016/j.ijpharm.2019.01.067.", "ArticleIdList": ["10.1016/j.ijpharm.2019.01.067", "30742987"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "8", "Day": "21"}, {"Year": "2020", "Month": "9", "Day": "11"}, {"Year": "2020", "Month": "9", "Day": "17"}, {"Year": "2020", "Month": "9", "Day": "23", "Hour": "1", "Minute": "3"}, {"Year": "2020", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["32962182", "PMC7560163", "10.3390/ijms21186869", "ijms21186869"]}}], "PubmedBookArticle": []}